Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Research Precise Targeted RNASeq Assays

Cellular Research has launched its Precise targeted RNAseq assays. The company also announced the commercial availability of application-focused panels for the Precise assays, including panels for oncology, induced pluripotent stem cells, and immunology. The assays use next-generation sequencing alongside the company's Molecular Indexing technology as an alternative to qPCR. The assays are available in 96- and 384-sample formats, enabling customers to sequence up to 4,608 samples in a single sequencing run.